Acquisition by Rupert Vessey of 1625 shares of Bio Techne subject to Rule 16b-3

TECH Stock  USD 64.92  0.57  0.87%   
Under 73% of Bio Techne's investor base is looking to short. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that many investors are alarmed at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.
  
Filed transaction by Biotechne Corp director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Bio insider trading alert for grant of common stock by Rupert Vessey, the corporate stakeholder, on 30th of October 2023. This event was filed by Biotechne Corp with SEC on 2023-10-30. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Bio Techne's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Bio Techne's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Bio Techne Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Bio Techne can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
33.3%
67.8%
56.3%
60.2%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bio Techne Corp Historical Investor Sentiment

Investor biases related to Bio Techne's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Techne Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
News FrequencyInvestor Sentiment
Bio Techne's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Techne and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bio Techne news discussions. The higher the estimate score, the more favorable the investor's outlook on Bio Techne.

Bio Techne Fundamental Analysis

We analyze Bio Techne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Techne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earning

Price To Earning Comparative Analysis

Bio Techne is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Bio Techne Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Techne stock to make a market-neutral strategy. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics with similar companies.

Peers

Bio Techne Related Equities

EXELExelixis   5.02   
0%
73.0%
AKROAkero Therapeutics   2.49   
0%
36.0%
LEGNLegend Biotech   2.00   
0%
29.0%
HALOHalozyme Therapeutics   0.54   
0%
7.0%
ALNYAlnylam Pharmaceuticals   0.16   
2.0%
0%
BMRNBiomarin Pharmaceutical   0.70   
10.0%
0%
ASNDAscendis Pharma   1.39   
20.0%
0%
UTHRUnited Therapeutics   1.70   
25.0%
0%
BPMCBlueprint Medicines   2.23   
32.0%
0%
REPLReplimune   2.31   
34.0%
0%
LQDALiquidia Technologies   2.36   
34.0%
0%
APLSApellis Pharmaceuticals   2.93   
43.0%
0%
VTYXVentyx Biosciences   3.01   
44.0%
0%
PCVXVaxcyte   3.31   
48.0%
0%
NUVLNuvalent   3.52   
51.0%
0%
TVTXTravere Therapeutics   6.79   
100.0%
0%

Complementary Tools for Bio Stock analysis

When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments